latest news releases from the newsroom
SouthCrest Financial Group, Inc.
SouthCrest Financial Group, Inc. Announces Fourth Quarter Earnings
FAYETTEVILLE, Ga., Feb. 26, 2007 (PRIME NEWSWIRE) -- SouthCrest Financial Group, Inc. (OTCBB:SCSG) reported net income of $1,493,000 for the quarter ended December 31, 2006 compared to $1,154,000 for the same quarter a year ago. For the year ended December 31, 2006, net income was $5,774,000 compared to $4,844,000 for the same period in 2005. On a per share basis, results were $0.39 per share for the current quarter compared to $0.32 for the same period a year ago, and $1.59 per share for the year ended December 31, 2006 compared to $1.36 for the year ended December 31, 2005. Results for the 2005 quarter included a recognized loss on disposal of equipment of $184,000, or $114,000 net of tax.
Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology
ALAMEDA, Calif., Feb. 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today that the Cambridge University Press journal Neuron Glia Biology has published online the first article of its special issue about pain, featuring the use of Avigen's product, AV411 (ibudilast), a potential first-in-class oral treatment for the management of chronic neuropathic pain. AV411 is in early phase II clinical development in patients with neuropathic pain.